Evidence map›Paper›PMID 33381973›Full record

ArticleChemical research in toxicology2021

Effects of

Gunnar Boysen, Rashi Arora, Amanda Degner, Karin R Vevang, Christopher Chao, Freddys Rodriguez, Scott J Walmsley, Luke Erber, Natalia Y Tretyakova, Lisa A Peterson

Open access · greenAbstract read
In one paragraph

Article in Chemical research in toxicology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Frontiers in bioinformatics · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Gunnar BoysenDepartment of Medicinal Chemistry, University of Minnesota Minneapolis, Minnesota 55455, United States.ORCID 0000-0001-8364-9881
Rashi AroraUniversity of Minnesota Masonic Cancer Center, Minneapolis, Minnesota 55455, United States.
Amanda DegnerDepartment of Medicinal Chemistry, University of Minnesota Minneapolis, Minnesota 55455, United States.
Karin R VevangDivision of Environmental Health Sciences, University of Minnesota, Minneapolis, Minnesota 55455, United States.
Christopher ChaoDepartment of Medicinal Chemistry, University of Minnesota Minneapolis, Minnesota 55455, United States.
Freddys RodriguezDepartment of Medicinal Chemistry, University of Minnesota Minneapolis, Minnesota 55455, United States.
Scott J WalmsleyUniversity of Minnesota Masonic Cancer Center, Minneapolis, Minnesota 55455, United States.ORCID 0000-0003-2108-1121
Luke ErberDepartment of Medicinal Chemistry, University of Minnesota Minneapolis, Minnesota 55455, United States.
Natalia Y TretyakovaDepartment of Medicinal Chemistry, University of Minnesota Minneapolis, Minnesota 55455, United States.ORCID 0000-0002-0621-6860
Lisa A PetersonUniversity of Minnesota Masonic Cancer Center, Minneapolis, Minnesota 55455, United States.ORCID 0000-0001-8715-4480
University of Minnesota · US

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Jeffrey S. Miller · 1998 to 2026
$100.4M
Untargeted Adductomics to Characterize Ethnic Differences in the Exposome of SmokersP01CA138338 · NCI · UNIVERSITY OF MINNESOTA · PI Daniel O Stram · 2010 to 2026
$33.4M
Training Research Educators in Minnesota (TREM) whilst increasing diversityK12GM119955 · NIGMS · UNIVERSITY OF MINNESOTA · PI David Irwin Greenstein, Julia Willett · 2017 to 2026
$6.5M
DNA Cross-Linking By DiepoxybutaneR01CA100670 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI TRETYAKOVA, NATALIA Y · 2003 to 2021
$3.5M
Chromatin regions, genes and pathways that confer susceptibility to chemical-induced DNA damageR01ES029911 · NIEHS · TEXAS A&M AGRILIFE RESEARCH · PI RUSYN, IVAN, THREADGILL, DAVID W. · 2019 to 2023
$3.3M
Training the Next Generation of Chemical BiologistsT32GM132029 · NIGMS · UNIVERSITY OF MINNESOTA · PI Erin Elizabeth Carlson, William Charles Krause Pomerantz · 2019 to 2026
$2.7M
NCI NIH HHS P01 CA138338NCI NIH HHS P30 CA077598NCI NIH HHS R01 CA100670NIEHS NIH HHS R01 ES029911NIGMS NIH HHS K12 GM119955NIGMS NIH HHS T32 GM132029
6 · The paper itself

Abstract

Smoking is a leading cause of lung cancer, accounting for 81% of lung cancer cases. Tobacco smoke contains over 5000 compounds, of which more than 70 have been classified as human carcinogens. Of the many tobacco smoke constituents, 1,3-butadiene (BD) has a high cancer risk index due to its tumorigenic potency and its abundance in cigarette smoke. The carcinogenicity of BD has been attributed to the formation of several epoxide metabolites, of which 1,2,3,4-diepoxybutane (DEB) is the most toxic and mutagenic. DEB is formed by two oxidation reactions carried out by cytochrome P450 monooxygenases, mainly CYP2E1. Glutathione-S-transferase

Indexed as

Cell LineDNADNA AdductsEpoxy CompoundsGenotypeGlutathioneGlutathione TransferaseHumansMolecular StructurediepoxybutaneDNADNA AdductsEpoxy CompoundsGlutathioneglutathione S-transferase T1Glutathione Transferase

Identifiers

PMID33381973
PMCPMC8177101
OpenAlexW3115460517

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.